ÂÜÀòÂÒÂ×

Bruce Widmer is a Senior Digital Product Analyst at Prime Therapeutics since January 2021. Prior to this role, Bruce served as a Business Analyst and Senior QA Analyst at Refinitiv from October 2018 to March 2020, where responsibilities included leading a web platform team during a manager's leave. Bruce's extensive experience at Thomson Reuters spanned nearly two decades from December 1998 to October 2018, performing as a Senior QA Analyst and Business Analyst for mobile applications, contributing to quality assurance for projects with significant budgets using Agile methodology. Early career roles included being a Senior Quality Assurance Specialist and a Consultant on Customer and Technical Support teams. Bruce holds a Bachelor of Arts degree in Spanish Language and Literature from the University of Minnesota.